Vigil Neuroscience Statistics
Total Valuation
VIGL has a market cap or net worth of $89.14 million. The enterprise value is $4.29 million.
Important Dates
The last earnings date was Thursday, March 13, 2025, before market open.
| Earnings Date | Mar 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VIGL has 46.67 million shares outstanding. The number of shares has increased by 5.05% in one year.
| Current Share Class | 46.67M |
| Shares Outstanding | 46.67M |
| Shares Change (YoY) | +5.05% |
| Shares Change (QoQ) | +2.66% |
| Owned by Insiders (%) | 0.92% |
| Owned by Institutions (%) | 39.92% |
| Float | 27.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.09 |
| P/TBV Ratio | 1.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.95 |
| Quick Ratio | 2.88 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -89.69% and return on invested capital (ROIC) is -52.22%.
| Return on Equity (ROE) | -89.69% |
| Return on Assets (ROA) | -43.36% |
| Return on Invested Capital (ROIC) | -52.22% |
| Return on Capital Employed (ROCE) | -107.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.22M |
| Employee Count | 69 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.31% in the last 52 weeks. The beta is 1.84, so VIGL's price volatility has been higher than the market average.
| Beta (5Y) | 1.84 |
| 52-Week Price Change | -40.31% |
| 50-Day Moving Average | 2.33 |
| 200-Day Moving Average | 3.07 |
| Relative Strength Index (RSI) | 39.47 |
| Average Volume (20 Days) | 168,358 |
Short Selling Information
The latest short interest is 419,345, so 0.90% of the outstanding shares have been sold short.
| Short Interest | 419,345 |
| Short Previous Month | 563,983 |
| Short % of Shares Out | 0.90% |
| Short % of Float | 1.50% |
| Short Ratio (days to cover) | 1.88 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -89.68M |
| Pretax Income | -82.78M |
| Net Income | -84.26M |
| EBITDA | -89.23M |
| EBIT | -89.68M |
| Earnings Per Share (EPS) | -$2.07 |
Full Income StatementBalance Sheet
The company has $97.80 million in cash and $12.95 million in debt, giving a net cash position of $84.85 million or $1.82 per share.
| Cash & Cash Equivalents | 97.80M |
| Total Debt | 12.95M |
| Net Cash | 84.85M |
| Net Cash Per Share | $1.82 |
| Equity (Book Value) | 71.64M |
| Book Value Per Share | 1.75 |
| Working Capital | 66.44M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$51.22 million and capital expenditures -$5,000, giving a free cash flow of -$51.23 million.
| Operating Cash Flow | -51.22M |
| Capital Expenditures | -5,000 |
| Free Cash Flow | -51.23M |
| FCF Per Share | -$1.10 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |